OPTN - OptiNose Corp Total Debt to Capital

Serving as the primary valuation tool, this chart on GURU.Markets shows the 0.00 indicator, while the financial stability of OptiNose, Inc. (OPTN) remains stable due to the sale of nasal systems. However, trade barriers and logistical disruptions are increasing component production costs, thereby reducing export margins. Business development relies on partnerships with distributors to scale the implementation of XHANCE technologies.

This metric compares total liabilities to net assets, allowing for an assessment of financial leverage and the resilience of the capital structure to external shocks. For OptiNose, Inc. (OPTN), which is developing diversified drug delivery systems, the total debt-to-equity ratio demonstrates the extent to which expansion into the migraine and sinusitis treatment markets is financed through borrowed funds rather than equity.